Cargando…
Systematic Review: microRNAs as Potential Biomarkers in Mild Cognitive Impairment Diagnosis
The rate of progression from Mild Cognitive Impairment (MCI) to Alzheimer's disease (AD) is estimated at >10% per year, reaching up to 80–90% after 6 years. MCI is considered an indicator of early-stage AD. In this context, the diagnostic screening of MCI is crucial for detecting individuals...
Autores principales: | Ogonowski, Natalia, Salcidua, Stefanny, Leon, Tomas, Chamorro-Veloso, Nayaret, Valls, Cristian, Avalos, Constanza, Bisquertt, Alejandro, Rentería, Miguel E., Orellana, Paulina, Duran-Aniotz, Claudia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790149/ https://www.ncbi.nlm.nih.gov/pubmed/35095478 http://dx.doi.org/10.3389/fnagi.2021.807764 |
Ejemplares similares
-
Systematic review: fluid biomarkers and machine learning methods to improve the diagnosis from mild cognitive impairment to Alzheimer’s disease
por: Blanco, Kevin, et al.
Publicado: (2023) -
Latin American women in dementia research: outstanding contributions, barriers, and opportunities from Argentinian, Chilean, and Colombian colleagues
por: Fittipaldi, Sol, et al.
Publicado: (2023) -
Editorial: Protein Misfolding and Proteostasis Impairment in Aging and Neurodegeneration: From Spreading Studies to Therapeutic Approaches
por: Duran-Aniotz, Claudia, et al.
Publicado: (2022) -
New Roles for MicroRNAs in Old Worms
por: Elder, Corrina R., et al.
Publicado: (2022) -
Aged Cattle Brain Displays Alzheimer's Disease-Like Pathology and Promotes Brain Amyloidosis in a Transgenic Animal Model
por: Moreno-Gonzalez, Ines, et al.
Publicado: (2022)